Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    01191086
Show Display Options
Rank Status Study
1 Completed Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures
Condition: Epilepsy
Intervention: Drug: USL255

Indicates status has not been verified in more than two years